Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $252.67 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2024) |
| Philips North America LLC | $72.06 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $24.80 | 2 | $0 (2020) |
| Philips Electronics North America Corporation | $19.09 | 1 | $0 (2023) |
| Allergan Inc. | $11.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.06 | 5 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $19.09 | 1 | Philips Electronics North America Corporation ($19.09) |
| 2020 | $13.67 | 1 | GlaxoSmithKline, LLC. ($13.67) |
| 2018 | $11.13 | 1 | GlaxoSmithKline, LLC. ($11.13) |
| 2017 | $11.72 | 1 | Allergan Inc. ($11.72) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Medical Device | ||||||
| 11/12/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Medical Device | ||||||
| 09/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Medical Device | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/10/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Medical Device | ||||||
| 12/06/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: Medical Device | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,287 | 2,134 | $536,510 | $176,119 |
| 2022 | 20 | 1,578 | 3,208 | $906,688 | $254,887 |
| 2021 | 21 | 1,635 | 3,199 | $944,586 | $268,339 |
| 2020 | 18 | 1,562 | 3,215 | $1.0M | $279,089 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 4 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 63 | 186 | $14,089 | $10,773 | 76.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 94 | 159 | $38,160 | $10,212 | 26.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 72 | 322 | $15,326 | $10,153 | 66.2% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2020 | 64 | 74 | $7,214 | $5,548 | 76.9% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2020 | 20 | 32 | $20,480 | $5,051 | 24.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 26 | 32 | $3,154 | $2,361 | 74.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 12 | 13 | $1,894 | $1,498 | 79.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 23 | 23 | $2,530 | $1,403 | 55.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 28 | $7,140 | $1,310 | 18.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 37 | 37 | $2,775 | $704.85 | 25.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 17 | 17 | $825.48 | $606.33 | 73.5% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 14 | 14 | $560.00 | $268.38 | 47.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 18 | 20 | $1,000 | $192.73 | 19.3% |
About Dr. Edward Mezic, MD
Dr. Edward Mezic, MD is a Pulmonary Disease healthcare provider based in Old Bridge, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437218435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Mezic, MD has received a total of $252.67 in payments from pharmaceutical and medical device companies, with $197.06 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($252.67).
As a Medicare-enrolled provider, Mezic has provided services to 6,062 Medicare beneficiaries, totaling 11,756 services with total Medicare billing of $978,435. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Old Bridge, NJ
- Active Since 12/06/2006
- Last Updated 05/18/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1437218435
Products in Payments
- TEZSPIRE (Biological) $125.00
- (AK6) Vest Therapy (Device) $54.29
- (8874) inCourage (Device) $36.86
- TRELEGY ELLIPTA (Drug) $24.80
- VRAYLAR (Drug) $11.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Old Bridge
Joseph Mathew, Md, MD
Pulmonary Disease — Payments: $3,932
Edward Lee, M.d, M.D
Pulmonary Disease — Payments: $1,489
Kishore Ratkalkar, Md, MD
Pulmonary Disease — Payments: $216.78
Dr. Raj Dhakhwa, M.d, M.D
Pulmonary Disease — Payments: $32.78